SAVA
Cassava Sciences Inc
-13.96%
$29.88 - $25.71
Feb 7th 2023 - Mar 21st 2023
Mar, 21, 2023
Data tells me no safety issues, with a possible la... See more
Feb, 25, 2023
Then they dropped the “good” totally “not disappoi... See more
AVXL
Anavex Life Sciences Corporation
-22.55%
$11.75 - $9.10
Feb 7th 2023 - Mar 21st 2023
Mar, 5, 2023
We are excited about the data and plan to submit t... See more
Mar, 3, 2023
$AVXL Australia trial data meets the gold standard.
Mar, 21, 2023
Data tells me no safety issues, with a possible large therapeutic window.
Feb, 25, 2023
Then they dropped the “good” totally “not disappointing” data that Remi was so “Thrilled” about.
Feb, 24, 2023
This will go beyond parabolic on good data … literally no shares out there unless they offer new ones … $MDGL $VKTX $SLS $SAVA
Feb, 6, 2023
SAVA data gets analyzed by multiple different labs and shows its cognition improvement in mild AD cases, safe and well-tolerated
Jan, 30, 2023
$SAVA I love not being able to hold $28 off data that will keep it pinned here until 2024.
Jan, 30, 2023
but the data to date would predict continued efficacy that will be nigh on impossible to ignore.
Jan, 30, 2023
Data teasing is very positive. 🚀
Jan, 18, 2023
$SAVA Institutional buying says data is good!! !
Jan, 18, 2023
I’ll keep buying until data comes out…
Jan, 17, 2023
Excited for the next data unveiling….bring it on!
Mar, 5, 2023
We are excited about the data and plan to submit the data for publication and peer reviewed medical journal in the near term.
Mar, 3, 2023
$AVXL Australia trial data meets the gold standard.
Feb, 24, 2023
$AVXL - Alz Topline Data was solid ..
Feb, 14, 2023
Efficacy is likey overwhelming after seeing 👀 data details!
Feb, 14, 2023
$AVXL I am extremely bullish on the data .. the FDA can ask any sorts of questions
Jan, 31, 2023
I'm looking forward to seeing the long term AD data on ANVS and have the feeling it's going to end up being the best in class AD treatment as well.
Jan, 28, 2023
Now DATA met expectations.
Jan, 24, 2023
Also clint said every time Blarcamesine data comes back it looks better and better. .
Jan, 24, 2023
Anavex has significant 4 years of ph2/3 safety data with safety back to 2013 for Blarcamesine .. anavex has full 3 endpoint trial and a placebo .. it's obvious Anavex wins!!
Jan, 22, 2023
So I think the data so far was encouraging,
Mar, 15, 2023
Solid data !
Mar, 4, 2023
Get Ready for better data coming !
Jan, 13, 2023
we just today got a great CPI data as per expectations.
Jan, 12, 2023
$BABA $eh $VNET $lu $MLCO tomorrow’s CPI data comes out to be better than expected, everything will go up.
Jan, 4, 2023
VNET is one of the largest data centers companies in China and as investors are getting more comfortable investing in China this can rocket high very soon.
Dec, 25, 2022
Big data analytics winning !
Dec, 13, 2022
$BABA Market seems bullish before the CPI data release tomorrow, latest economic calendar shows all of the critical economic updates for tomorrow, that can impact the overall market and BABA stock https://thefinanceheadline.com/economic-calendar/
Nov, 15, 2022
$GOOGL $BABA $UPST $AAPL THE DATA LOOKING GREAT AS EXPECTED.